Amble Tirzepatide 99% White Powder - High Purity Weight Loss Peptide Supplier

Amble Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The unique mechanism of Amble Tirzepatide involves simultaneous activation of both GIP and GLP-1 receptors, with preferential binding to GIP receptors. This dual action produces significant reductions in hyperglycemia and offers multiple metabolic benefits for research purposes.

Key Research Applications:

- Investigation of glucose metabolism regulation
- Study of appetite suppression mechanisms
- Research into weight management pathways
- Examination of insulin secretion processes
- Exploration of triglyceride reduction effects

Amble Tirzepatide has shown promising results in clinical research settings, particularly in studies examining its effects on hemoglobin A1c reduction, postprandial glucose control, and potential conversion of white adipose tissue to brown fat.

This product is supplied as a white to off-white lyophilized powder with high purity and stability when stored properly. It is intended for laboratory research use only, not for human consumption.